Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2019-09-30
Product name:
MOXIFLOXACIN OPHTHALMIC SOLUTION
DIN:
02485702
Product Monograph/Veterinary Labelling:
Date:
2019-02-11
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
BEXIMCO PHARMACEUTICALS CANADA LIMITED
80 Dunstall Crescent
Toronto
Ontario
Canada
M1E 3M4
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Ophthalmic
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
52:04.04
Anatomical Therapeutic Chemical (ATC): See footnote 4
S01AE07 MOXIFLOXACIN
Active ingredient group (AIG) number:See footnote5
0142242003
Active ingredient(s) | Strength |
---|---|
MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) | 0.5 % / W/V |